Latest Breaking News On - Office of scientific investigations - Page 7 : comparemela.com

ATTENTION NASDAQ: BIVI INVESTORS: Contact Berger Montague

PHILADELPHIA, Feb. 03, 2024 (GLOBE NEWSWIRE) Berger Montague advises investors that a securities fraud class action lawsuit has been filed against.

United statesSan franciscoSan diegoBerger montagueJames maroAndrew abramowitzBiovie incDrug administrationOffice of scientific investigationsClass periodCarson cityGood clinical practiceScientific investigationsBerger montagueLass actionSecurities fraud

ATTENTION NASDAQ: BIVI INVESTORS: Contact Berger Montague About a BioVie Inc Class Action Lawsuit

ATTENTION NASDAQ: BIVI INVESTORS: Contact Berger Montague About a BioVie Inc Class Action Lawsuit
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoSan franciscoJames maroBerger montagueAndrew abramowitzOffice of scientific investigationsDrug administrationBiovie incClass periodCarson cityGood clinical practiceScientific investigations

BIOVIE INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi

If you suffered losses exceeding $25,000 investing in BioVie stock or options between August 5, 2021 and November 29, 2023 and would like to discuss your.

United statesNew yorkJosh wilsonOffice of scientific investigationsBiovie incDrug administrationWilson faruqiDefendant phaseGood clinical practiceScientific investigationsFaruqi amp llpAruqi amp faruqiAruqi lawLass actionClass action lawsuitBiovie inc

BIOVIE SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In BioVie To Contact Him Directly To Discuss Their Options -February 02, 2024 at 11:16 am EST

If you suffered losses exceeding $25,000 investing in BioVie stock or options between August 5, 2021 and November 29, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner.

United statesNew yorkPrnewswire faruqiJosh wilsonOffice of scientific investigationsDrug administrationBiovie incDefendant phaseGood clinical practiceScientific investigations

BIOVIE SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In BioVie To Contact Him Directly To Discuss Their Options

/PRNewswire/ Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against BioVie Inc. ("BioVie" or the "Company").

New yorkUnited statesPrnewswire faruqiJosh wilsonBiovie incDrug administrationOffice of scientific investigationsDefendant phaseGood clinical practiceScientific investigationsFaruqi amp